NOVA EYE MEDICAL LIMITED (EYE.AX) Financial Forecast
Australia · Health Care · AUD (Thousands) · Annual
Key financials
AUD|Thousands
ROE
-47.76%
2026 (actual)
ROA
-34.18%
2026 (actual)
Gross Margin
68.56%
2026 (actual)
Net Margin
-30.95%
2026 (actual)
Total Assets
A$26,504.00K
2026 (actual)
Net Income
-A$9,059.00K
2026 (actual)
Valuation
-
Stock Price
-
Historical & projected performance
AUD|Thousands
Reported figures and Equlion model projections for the next 5 years.
ROE
+96.5 pt
Company
ROA
-24.1 pt
Company
Gross Margin
-9.8 pt
Company
Sector average
Net Margin
-10.4 pt
Company
Total Assets
+22.8%
Company
Sector average (own scale)
Net Income
-102.7%
Company
Sector average
Detailed data
AUD|Thousands
Amounts in AUD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for NOVA EYE MEDICAL LIMITED? It covers the balance sheet, income statement, cash flow and Equlion model projections.